There are 20 news based on search keyword " therapy"

DHCG, KunTuo Sign China Clinical Trials Collaboration

KUALA LUMPUR, May 12 (Bernama) -- Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and Development (Beijing) Co Ltd (KunTuo) signed a memorandum of understanding to establish a strategic collaboration supporting biotherapeutics developers conducting clinical trials in China.

AGC Biologics Honoured For Leadership In Regulatory, Quality Compliance

KUALA LUMPUR, April 28 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has won the 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance.

DHCG, Porton Advanced Partner To Accelerate Cell, Gene Therapies Development

KUALA LUMPUR, April 28 (Bernama) -- Dark Horse Consulting Group (DHCG) has signed a memorandum of understanding (MoU) with Porton Advanced to establish a strategic collaboration aimed at accelerating the development and clinical translation of cell and gene therapies globally.

Cirrus Expands To Singapore, Advances Novel Eye Therapies

KUALA LUMPUR, March 4 (Bernama) -- Cirrus Therapeutics, a global ocular immunology company, announced several business and pipeline updates to support its strategy of advancing first-in-class and best-in-class therapies for chronic blinding diseases.

MFA Targets RM600 Mln Potential Investments From Franchise International Malaysia 2026

KUALA LUMPUR, Feb 12 (Bernama) -- The Malaysian Franchise Association (MFA) is targeting an estimated RM600 million in potential investment value from the Franchise International Malaysia (FIM) 2026 exhibition, up from RM424 million recorded last year.

Helus Pharma Rebrands, Debuts On Nasdaq

KUALA LUMPUR, Jan 6 (Bernama) -- Helus Pharma, formerly Cybin Inc, marked its transition toward commercialisation as it began trading on the Nasdaq Global Market and Cboe Canada under the ticker symbol HELP, reflecting a strategic rebrand and corporate repositioning.

Australis Scientific Wins 2025 MedTech Innovator Asia Pacific Grand Prize 

KUALA LUMPUR, Oct 31 (Bernama) -- Australis Scientific has been named the 2025 MedTech Innovator (MTI) Asia Pacific (APAC) Grand Prize winner, receiving US$175,000 in non-dilutive funding for its smart patch that delivers minimally invasive neuromodulation therapy for overactive bladder. (US$1=RM4.19)

KFSHRC To Launch Saudi Arabia's First Genetic And Cellular Therapy Plant By 2025

KUALA LUMPUR, Oct 30 (Bernama) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) will open Saudi Arabia’s first facility for manufacturing genetic and cellular therapies by late 2025, a move set to transform patient care and the nation’s biotech landscape.

Highlights From Budget 2026

KUALA LUMPUR, Oct 10 (Bernama) -- Below are the highlights from Budget 2026, themed the Fourth MADANI Budget: People’s Budget, which was tabled by Prime Minister and Finance Minister Datuk Seri Anwar Ibrahim.

Budget 2026: Excise Duty For Cigarettes Up 2 Sen Per Stick, 10 Pct Rise For Alcohol - PM Anwar

KUALA LUMPUR, Oct 10 (Bernama) -- Prime Minister Datuk Seri Anwar Ibrahim said excise duties for cigarette and alcohol products will be raised effective Nov 1, 2025 under the Budget 2026.

KUSKOP Launches Trade Mission To China To Strengthen Malaysian Franchise Brands

PUTRAJAYA, Aug 9 (Bernama) -- The Ministry of Entrepreneur and Cooperatives Development (KUSKOP) in collaboration with the Malaysian Franchise Association (MFA) launched an international trade mission to China starting yesterday until Aug 10.

Dr Falk Pharma, Allianthera Partner To Develop Novel AhR Agonist 

KUALA LUMPUR, July 30 (Bernama) -- Dr Falk Pharma GmbH and Allianthera have announced a strategic agreement to co-develop and commercialise ATB102, an aryl hydrocarbon receptor (AhR) agonist currently in Phase 1 trials in the United States.